Exhibition Report: Participated in JAPAN INNOVATION DAY 2025 by ASCII STARTUP
On February 28, 2025, Epistra exhibited at “JAPAN INNOVATION DAY 2025 by ASCII STARTUP (JID 2025).” The event was held at Belle Salle Shiodome in Tokyo, serving as a nexus of cutting-edge technology and business where startups, major corporations, and investors converge.
On the day, we showcased our AI optimization solution “Epistra Accelerate,” highlighting its contributions to cell culture condition optimization and efficiency improvement and cost reduction in research and development.
CEO Ozawa Delivered a Startup Pitch
Additionally, CEO Yosuke Ozawa took the stage at the startup pitch showcase held during the event to present Epistra’s technology. In a limited time, he delivered a presentation on transforming research and development through AI technology and future business directions, generating strong interest from many participants and receiving a significant response.
Related Articles
Epistra Contributes Article on "AI-Robot-Driven Drug Development" to Pharmacia, Journal of the Pharmaceutical Society of Japan
Epistra CTO Taku Tsuzuki and CEO Yosuke Ozawa contributed an article on AI-robot-driven drug development to Pharmacia, Vol. 62 No. 7, published by the Pharmaceutical Society of Japan.
Cell Culture Optimization Software 'CellTune Ver.2' Launches Globally
Epistra Inc. announces the global launch of 'CellTune Ver.2,' the updated version of the co-developed cell culture optimization software with Shimadzu Corporation, on June 29, 2026. The new version introduces cloud-based subscription delivery and overseas expansion of custom media manufacturing services.
Speaking Engagement: CEO Yosuke Ozawa Presented at the 10th Shonan iPark Regenerative Medicine Seminar
On June 3, 2026, Epistra Inc. CEO Yosuke Ozawa presented at the 10th Shonan iPark Regenerative Medicine Seminar, sharing implementation case studies and future prospects for AI and mathematical optimization in regenerative medicine process development.